AerSale Corporation (ASLE)

As a hedge fund PM reviewing the Q2 2026 print for AerSale (ASLE), the 12.7% revenue miss and massive EPS surprise ($ -0.09 vs $0.07 estimate) underscore severe execution flaws. The absence of flight equipment sales completely derailed the top line down to $70.9 million, dragging adjusted EBITDA down to a meager $2.2 million. Until management provides transparent guidance and proves they can convert their $376 million inventory base efficiently, we are remaining extremely cautious on sizing.

On our quant desk, ASLE's post-earnings drop of 8.4% highlights immediate downside vulnerability. The compression in adjusted EBITDA margin to 3.1% from last year's 17% territory demonstrates that facility expansion costs and slow maintenance volume growth are crushing short-term profitability. Feedstock acquisitions plummeting to $5.6 million from $27.1 million further confirm compressed USM activity in a highly competitive market.

From a bio-analyst and market structure lens, understanding AerSale's pivot to recurring lease and MRO revenue is essential. Although TechOps revenue rose nearly 9% on CRJ700/900 maintenance, it wasn't enough to mask the absence of high-margin engine sales that saved the prior year's period. Analysts need to drill down on whether the current $133 million in aircraft and engines held for lease can actually monetize fast enough to offset inventory holding costs.

Managing risk on ASLE right now requires recognizing that the stock is currently categorized as a high-risk buy with a revised price target between $8.33 and $9.36. The lack of clear guidance from CEO Nicolas Finazzo and CFO Martin Garmendia during the Q2 call amplifies timing risks regarding asset monetization. We are utilizing strict stop-losses given the disconnect between management's projections and actual operational delivery.

Watching the 50-day moving average and options sentiment on ASLE, the consensus among market participants is that poor execution is overshadowing any tangible book value support. Net income swung from a positive $8.6 million down to a net loss of $5.6 million in Q2 2026. Until cash conversion metrics show genuine improvement, institutional accumulation is likely to remain muted.